{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:13:29Z","timestamp":1749096809026,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"DOI":"10.7759\/cureus.85341","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:17:38Z","timestamp":1749046658000},"source":"Crossref","is-referenced-by-count":0,"title":["Ovarian Responses and Outcomes of In Vitro Fertilization Following Progesterone-Primed Ovarian Stimulation and Gonadotropin-Releasing Hormone (GnRH) Antagonist Protocols Using Follitropin Delta"],"prefix":"10.7759","author":[{"given":"Masachi","family":"Hanaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata B","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update. 2021, 27:48-66. 10.1093\/humupd\/dmaa040","journal-title":"Hum Reprod Update"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac040","article-title":"What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis","volume":"29","author":"Venetis CA","year":"2023","unstructured":"Venetis CA, Storr A, Chua SJ, Mol BW, Longobardi S, Yin X, D'Hooghe T. What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Hum Reprod Update. 2023, 29:307-26. 10.1093\/humupd\/dmac040","journal-title":"Hum Reprod Update"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey P","year":"2011","unstructured":"Devroey P, Polyzos NP, Blockeel C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod. 2011, 26:2593-7. 10.1093\/humrep\/der251","journal-title":"Hum Reprod"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020)","volume":"2020","author":"Ovarian Stimulation TE","year":"2020","unstructured":"Ovarian Stimulation TE, Bosch E, Broer S, et al.. ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020). Hum Reprod Open. 2020, 2020:009. 10.1093\/hropen\/hoaa009","journal-title":"Hum Reprod Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.18.10978","article-title":"The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor","volume":"95","author":"Skinner DC","year":"1998","unstructured":"Skinner DC, Evans NP, Delaleu B, Goodman RL, Bouchard P, Caraty A. The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc Natl Acad Sci U S A. 1998, 95:10978-83. 10.1073\/pnas.95.18.10978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang Y","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, et al.. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015, 104:62-70. 10.1016\/j.fertnstert.2015.03.022","journal-title":"Fertil Steril"},{"key":"ref7","article-title":"Comparison of clinical outcomes of progestational ovulation induction (PPOS) using follitropin Delta by time of initiation of progestational hormone","volume":"41","author":"Ozawa N","year":"2024","unstructured":"Ozawa N, Iwami N, Kawamata M, et al.. Comparison of clinical outcomes of progestational ovulation induction (PPOS) using follitropin Delta by time of initiation of progestational hormone. J Fertil Implant. 2024, 41:178-86.","journal-title":"J Fertil Implant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw047","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin N","year":"2017","unstructured":"Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017, 23:211-20. 10.1093\/humupd\/dmw047","journal-title":"Hum Reprod Update"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmab008","article-title":"Ovarian stimulation for oocyte donation: a systematic review and meta-analysis","volume":"27","author":"Martinez F","year":"2021","unstructured":"Martinez F, Racca A, Rodr\u00edguez I, Polyzos NP. Ovarian stimulation for oocyte donation: a systematic review and meta-analysis. Hum Reprod Update. 2021, 27:673-96. 10.1093\/humupd\/dmab008","journal-title":"Hum Reprod Update"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000909","article-title":"Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"94","author":"Zhu X","year":"2015","unstructured":"Zhu X, Zhang X, Fu Y. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Medicine (Baltimore). 2015, 94:909. 10.1097\/MD.0000000000000909","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal MD","year":"2024","unstructured":"Vidal MD, Mart\u00ednez F, Rodr\u00edguez I, Polyzos NP. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles. Hum Reprod. 2024, 39:1098-104. 10.1093\/humrep\/deae047","journal-title":"Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen A","year":"2017","unstructured":"Nyboe Andersen A, Nelson SM, Fauser BC, Garc\u00eda-Velasco JA, Klein BM, Arce JC. Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017, 107:387-396. 10.1016\/j.fertnstert.2016.10.033","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.01.023","article-title":"Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial","volume":"42","author":"Ishihara O","year":"2021","unstructured":"Ishihara O, Arce JC. Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial. Reprod Biomed Online. 2021, 42:909-18. 10.1016\/j.rbmo.2021.01.023","journal-title":"Reprod Biomed Online"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"Qiao J","year":"2021","unstructured":"Qiao J, Zhang Y, Liang X, et al.. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients. Hum Reprod. 2021, 36:2452-62. 10.1093\/humrep\/deab155","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-024-03146-1","article-title":"The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials","volume":"41","author":"Doroftei B","year":"2024","unstructured":"Doroftei B, Ilie OD, Dabuleanu AM, Armeanu T, Maftei R. The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials. J Assist Reprod Genet. 2024, 41:1851-61. 10.1007\/s10815-024-03146-1","journal-title":"J Assist Reprod Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.05.143","article-title":"Individualized dosing of follitropin delta affects live birth and safety in in\u00a0vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials","volume":"122","author":"Nelson SM","year":"2024","unstructured":"Nelson SM, Shaw M, Alrashid K, Anderson RA. Individualized dosing of follitropin delta affects live birth and safety in in\u00a0vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials. Fertil Steril. 2024, 122:445-54. 10.1016\/j.fertnstert.2024.05.143","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01372-w","article-title":"Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization\/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis","volume":"17","author":"Palomba S","year":"2024","unstructured":"Palomba S, Caserta D, Levi-Setti PE, Busnelli A. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization\/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis. J Ovarian Res. 2024, 17:60. 10.1186\/s13048-024-01372-w","journal-title":"J Ovarian Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.07.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology world report: assisted reproductive technology, 2015 and 2016","volume":"122","author":"Kupka MS","year":"2024","unstructured":"Kupka MS, Chambers GM, Dyer S, et al.. International Committee for Monitoring Assisted Reproductive Technology world report: assisted reproductive technology, 2015 and 2016. Fertil Steril. 2024, 122:875-93. 10.1016\/j.fertnstert.2024.07.009","journal-title":"Fertil Steril"},{"key":"ref19","article-title":"Timing of antagonist intervention in ovulation-induction using a follitropin Delta (Rekovelle) subcutaneous injection pen","volume":"41","author":"Hanaoka M","year":"2024","unstructured":"Hanaoka M, Hanaoka K, Yamada M. Timing of antagonist intervention in ovulation-induction using a follitropin Delta (Rekovelle) subcutaneous injection pen. J Fertil Implant. 2024, 41:218-23.","journal-title":"J Fertil Implant"},{"key":"ref20","unstructured":"2022 clinical outcomes of in vitro fertilization and embryo transfer. (2022). https.\/\/www.jsog.or.jp\/activity\/art\/2022_JSOG-ART.pdf."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20250003","article-title":"Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles","author":"Souza MM","year":"2025","unstructured":"Souza MM, Souza MD, Antunes RA, et al.. Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles. JBRA Assist Reprod. 2025, 10.5935\/1518-0557.20250003","journal-title":"JBRA Assist Reprod"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81281","article-title":"Comparison of assisted reproductive technology (ART) outcomes in two controlled ovarian stimulation protocols using follitropin delta, a recombinant follicle-stimulating hormone (rFSH) injection","volume":"17","author":"Kokeguchi S","year":"2025","unstructured":"Kokeguchi S, Okamoto E, Shibahara H, Yamagami K, Furuhashi K, Enatsu N, Shiotani M. Comparison of assisted reproductive technology (ART) outcomes in two controlled ovarian stimulation protocols using follitropin delta, a recombinant follicle-stimulating hormone (rFSH) injection. Cureus. 2025, 17:81281. 10.7759\/cureus.81281","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57040379","article-title":"Follitropin delta as a state-of-the-art incorporated companion for assisted reproductive procedures: a two year observational study","volume":"57","author":"Doroftei B","year":"2021","unstructured":"Doroftei B, Ilie OD, Dabuleanu AM, Diaconu R, Maftei R, Simionescu G, Ilea C. Follitropin delta as a state-of-the-art incorporated companion for assisted reproductive procedures: a two year observational study. Medicina (Kaunas). 2021, 57:379. 10.3390\/medicina57040379","journal-title":"Medicina (Kaunas)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.12.011","article-title":"Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF\/ICSI procedures (DELTA Study)","volume":"293","author":"Porcu-Buisson G","year":"2024","unstructured":"Porcu-Buisson G, Maignien C, Swierkowski-Blanchard N, et al.. Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF\/ICSI procedures (DELTA Study). Eur J Obstet Gynecol Reprod Biol. 2024, 293:21-6. 10.1016\/j.ejogrb.2023.12.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.992677","article-title":"Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)","volume":"13","author":"Blockeel C","year":"2022","unstructured":"Blockeel C, Griesinger G, Rago R, Larsson P, Sonderegger YL, Rivi\u00e8re S, Laven JS. Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study). Front Endocrinol (Lausanne). 2022, 13:992677. 10.3389\/fendo.2022.992677","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01364-5","article-title":"Controlled ovarian stimulation (COS) with follitropin delta results in higher cumulative live birth rates compared with follitropin alfa\/beta in a large retrospectively analyzed real-world data set","volume":"23","author":"Eggersmann TK","year":"2025","unstructured":"Eggersmann TK, Sch\u00fctt M, Becker J, Kimmel M, Aust H, Winkler J, Freis A. Controlled ovarian stimulation (COS) with follitropin delta results in higher cumulative live birth rates compared with follitropin alfa\/beta in a large retrospectively analyzed real-world data set. Reprod Biol Endocrinol. 2025, 23:25. 10.1186\/s12958-025-01364-5","journal-title":"Reprod Biol Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76371","article-title":"Cost-effectiveness and clinical outcomes of controlled ovarian stimulation with follitropin Delta and follitropin alfa: a retrospective study","volume":"16","author":"Kobanawa M","year":"2024","unstructured":"Kobanawa M, Iwami N, Hanaoka M, Enatsu K, Ichiyama T. Cost-effectiveness and clinical outcomes of controlled ovarian stimulation with follitropin Delta and follitropin alfa: a retrospective study. Cureus. 2024, 16:76371. 10.7759\/cureus.76371","journal-title":"Cureus"},{"key":"ref28","article-title":"Exploratory comparison of new rFSH preparation follitropin delta\uff08Rekovelle\u00ae\uff09and HMG for controlled ovarian hyperstimulation (Article in Japanese)","volume":"25","author":"Hanaoka M","year":"2022","unstructured":"Hanaoka M, Hanaoka K, Yamada M. Exploratory comparison of new rFSH preparation follitropin delta\uff08Rekovelle\u00ae\uff09and HMG for controlled ovarian hyperstimulation (Article in Japanese). J Jpn Soc Assist Reprod. 2022, 25:4-8.","journal-title":"J Jpn Soc Assist Reprod"},{"key":"ref29","article-title":"Matching analysis with a focus on GnRH antagonist administration timing in induction using follitropin delta (Rekovelle pen for subcutaneous injection) (Article in Japanese)","volume":"1","author":"Hanaoka M","year":"2024","unstructured":"Hanaoka M, Hanaoka K, Yamada M. Matching analysis with a focus on GnRH antagonist administration timing in induction using follitropin delta (Rekovelle pen for subcutaneous injection) (Article in Japanese). J Jpn Soc Assist Reprod. 2024, 1:28-32.","journal-title":"J Jpn Soc Assist Reprod"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2020.12.002","article-title":"In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta","volume":"2","author":"Haakman O","year":"2021","unstructured":"Haakman O, Liang T, Murray K, et al.. In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta. F S Rep. 2021, 2:30-5. 10.1016\/j.xfre.2020.12.002","journal-title":"F S Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372402-ovarian-responses-and-outcomes-of-in-vitro-fertilization-following-progesterone-primed-ovarian-stimulation-and-gonadotropin-releasing-hormone-gnrh-antagonist-protocols-using-follitropin-delta","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:17:40Z","timestamp":1749046660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372402-ovarian-responses-and-outcomes-of-in-vitro-fertilization-following-progesterone-primed-ovarian-stimulation-and-gonadotropin-releasing-hormone-gnrh-antagonist-protocols-using-follitropin-delta"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.85341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}